Well, the bulk of the PR is re: the “Complete Vaccine” and NGIO IPO, but the very last sentence is “ I will also provide a complete corporate update including discussions of our subsidiaries”.

I would hope we would get a synopsis of the status and any short term plans from each of the subs. AltuCell is certainly pertinent. And I am very interested in a full update on the NuGen Health progress. Given what they told us on the last call, we deserve a “Complete Update” on that... I might trademark that term...